Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.

Tan ZM, Sun BC.

World J Gastroenterol. 2013 Dec 21;19(47):8895-901. doi: 10.3748/wjg.v19.i47.8895. Review.

PMID:
24379613
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.

Ishikawa T.

World J Gastroenterol. 2013 Dec 21;19(47):8861-6. doi: 10.3748/wjg.v19.i47.8861. Review.

PMID:
24379608
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus.

Lee JI, Kim JK, Chang HY, Lee JW, Kim JM, Chung HJ, Kim YS, Lee KS.

J Gastroenterol Hepatol. 2014 May;29(5):1019-27. doi: 10.1111/jgh.12472.

PMID:
24325315
[PubMed - indexed for MEDLINE]
4.

Antiviral therapy in patients with hepatitis B virus-related hepatocellular carcinoma: is it ready for universal application?

Lao XM, Xia HH, Lin XJ, Li SP.

J Viral Hepat. 2013 Dec;20(12):e148-9. doi: 10.1111/jvh.12147. Epub 2013 Jul 17. No abstract available.

PMID:
24304460
[PubMed - indexed for MEDLINE]
5.

Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.

Tanaka K, Yabushita Y, Nakagawa K, Kumamoto T, Matsuo K, Taguri M, Endo I.

Eur J Surg Oncol. 2013 Dec;39(12):1364-70. doi: 10.1016/j.ejso.2013.10.007. Epub 2013 Oct 23.

PMID:
24183169
[PubMed - indexed for MEDLINE]
6.

Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy?

Yu LH, Li N, Shi J, Guo WX, Wu MC, Cheng SQ.

Ann Surg Oncol. 2014 Mar;21(3):1010-5. Review.

PMID:
24121884
[PubMed - indexed for MEDLINE]
7.

Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study.

Yin J, Li N, Han Y, Xue J, Deng Y, Shi J, Guo W, Zhang H, Wang H, Cheng S, Cao G.

J Clin Oncol. 2013 Oct 10;31(29):3647-55. doi: 10.1200/JCO.2012.48.5896. Epub 2013 Sep 3. Erratum in: J Clin Oncol. 2013 Nov 10;31(32):4167. J Clin Oncol. 2014 May 1;32(13):1386-7.

PMID:
24002499
[PubMed - indexed for MEDLINE]
Free Article
8.

Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.

Wei Q, Xu X, Ling Q, Zhou B, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):251-5. Review.

PMID:
23742769
[PubMed - indexed for MEDLINE]
Free Article
9.

Antiviral therapy decreases viral reactivation in patients with hepatitis B virus-related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trial.

Huang L, Li J, Yan J, Sun J, Zhang X, Wu M, Yan Y.

J Viral Hepat. 2013 May;20(5):336-42. doi: 10.1111/jvh.12036. Epub 2012 Dec 5.

PMID:
23565616
[PubMed - indexed for MEDLINE]
10.

Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.

Lao XM, Luo G, Ye LT, Luo C, Shi M, Wang D, Guo R, Chen M, Li S, Lin X, Yuan Y.

Liver Int. 2013 Apr;33(4):595-604. doi: 10.1111/liv.12112. Epub 2013 Feb 13.

PMID:
23402625
[PubMed - indexed for MEDLINE]
11.

Role of antiviral therapy in the management of hepatocellular carcinoma.

Guan YS, He Q.

Anticancer Drugs. 2013 Apr;24(4):337-43. doi: 10.1097/CAD.0b013e32835ec39a. Review.

PMID:
23388161
[PubMed - indexed for MEDLINE]
12.

Lamivudine treatment enabling right hepatectomy for hepatocellular carcinoma in decompensated cirrhosis.

Honda K, Seike M, Maehara S, Tahara K, Anai H, Moriuchi A, Muro T.

World J Gastroenterol. 2012 May 28;18(20):2586-90. doi: 10.3748/wjg.v18.i20.2586.

PMID:
22654459
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.

Yang T, Lu JH, Zhai J, Lin C, Yang GS, Zhao RH, Shen F, Wu MC.

Eur J Surg Oncol. 2012 Aug;38(8):683-91. doi: 10.1016/j.ejso.2012.04.010. Epub 2012 May 22.

PMID:
22621971
[PubMed - indexed for MEDLINE]
14.

Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.

Urata Y, Kubo S, Takemura S, Uenishi T, Kodai S, Shinkawa H, Sakae M, Kaneda K, Ohata K, Nozawa A, Suehiro S.

J Hepatobiliary Pancreat Sci. 2012 Nov;19(6):685-96. doi: 10.1007/s00534-011-0489-z. Erratum in: J Hepatobiliary Pancreat Sci. 2012 Nov;19(6):697.

PMID:
22203455
[PubMed - indexed for MEDLINE]
15.

How does hepatitis B virus infection react to hepatocellular carcinoma treatment?

Wong GL.

J Gastroenterol Hepatol. 2012 Jan;27(1):1-2. doi: 10.1111/j.1440-1746.2011.06950.x. No abstract available.

PMID:
22188022
[PubMed - indexed for MEDLINE]
16.

Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.

Jin YJ, Shim JH, Lee HC, Yoo DJ, Kim KM, Lim YS, Suh DJ.

J Gastroenterol Hepatol. 2011 Sep;26(9):1380-8. doi: 10.1111/j.1440-1746.2011.06776.x.

PMID:
21884247
[PubMed - indexed for MEDLINE]
17.

Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.

Huang L, Li J, Lau WY, Yan J, Zhou F, Liu C, Zhang X, Shen J, Wu M, Yan Y.

J Gastroenterol Hepatol. 2012 Jan;27(1):158-64. doi: 10.1111/j.1440-1746.2011.06888.x.

PMID:
21871026
[PubMed - indexed for MEDLINE]
19.

Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.

Chan AC, Chok KS, Yuen WK, Chan SC, Poon RT, Lo CM, Fan ST.

Arch Surg. 2011 Jun;146(6):675-81. doi: 10.1001/archsurg.2011.125.

PMID:
21690443
[PubMed - indexed for MEDLINE]
20.

Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma.

An HJ, Jang JW, Bae SH, Choi JY, Cho SH, Yoon SK, Han JY, Lee KH, Kim DG, Jung ES.

J Gastroenterol Hepatol. 2010 Dec;25(12):1876-82. doi: 10.1111/j.1440-1746.2010.06416.x.

PMID:
21092000
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk